A study to compare two different forms of the same medicine (deferasirox tablet that is dissolved in liquid form vs. deferasirox granule form) to see how much of each type of medicine ends up in the blood. - Trial 2016-000307-93
Access comprehensive clinical trial information for 2016-000307-93 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Pharmaceuticals Corporation and is currently status unknown. The study focuses on Healthy subjects.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2016-000307-93
Trial Details
EU Clinical Trials Register • 2016-000307-93
A study to compare two different forms of the same medicine (deferasirox tablet that is dissolved in liquid form vs. deferasirox granule form) to see how much of each type of medicine ends up in the blood.
Study Focus
Sponsor & Location
Novartis Pharmaceuticals Corporation
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
-Primary PK parameters: AUClast, AUCinf and Cmax.
ICD-10 Classifications
Occupational health examination
Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
Routine child health examination
Examination and observation for other reasons
Data Source
EU Clinical Trials Register
2016-000307-93
Non-Device Trial